Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

• Autors principals: Tangui Barré (Autor), Fabrice Carrat (Autor), Clémence Ramier (Autor), Hélène Fontaine (Autor), Vincent Di Beo (Autor), Morgane Bureau (Autor), Céline Dorival (Autor), Dominique Larrey (Autor), Elisabeth Delarocque-Astagneau (Autor), Philippe Mathurin (Autor), Fabienne Marcellin (Autor), Ventzislava Petrov-Sanchez (Autor), Carole Cagnot (Autor), Patrizia Carrieri (Autor), Stanislas Pol (Autor), Camelia Protopopescu (Autor), the ANRS/AFEF Hepather study group (Autor)
• Format: Llibre
• Publicat: BMC, 2022-06-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Abstract Background Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated...